Letter: Variety in general practice.
D000477:Alkylating Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D010166:Palliative Care
D000477:Alkylating Agents; D000970:Antineoplastic Agents